Clinical Trials

Massive Bio SYNERGY-AI program matches Marginal Zone Lymphoma patients with active clinical trials.

We review your case and provide a list of options from the more than 30,000 available clinical trials throughout the United States.

  • You will be registered in SYNERGY-AI, our proprietary Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry platform.
  • You will receive a detailed report of eligible clinical trials powered by a state-of-the-art database, machine learning, and AI, focused on:
    • Novel immunotherapies, cell therapies, and cancer vaccines
    • Promising biomarkers based on your tumor type
    • Targeted drugs based on your cancer biomarkers and genomics
  • You will know all your options for the best clinical trials.
  • You will learn more about cancer research and how to use it to fight your cancer.
  • You will have access to the latest treatments and world-class care.

For a free clinical trial consultation to discuss your case, fill out the contact
form and a Cancer Care Specialist will call you within 24 hours.

    Marginal Zone B Cell Lymphoma

    Marginal Zone B Cell Lymphoma

    Marginal Zone B Cell Lymphomas are classified by slowly progressing (Indolent) diseases that affect the B-lymphocytes, a …

    Marginal Zone Lymphoma Staging

    Marginal Zone Lymphoma (MZL) Staging

    There are four total stages that contribute to Marginal Zone Lymphoma Staging (MZL). Staging is important to determine the …